Affiliation:
1. Department of Chemistry, College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China
Abstract
Advanced nanotechnology developed for PD-L1 detection and PD-L1/PD-1 immune checkpoint-relevant combined cancer therapies is reviewed.
Funder
National Key Research and Development Program of China
Beijing Municipal Natural Science Foundation
National Natural Science Foundation of China
Beijing University of Technology
Publisher
Royal Society of Chemistry (RSC)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献